OBJECTIVE: To present the clinical, biochemical, and genetic features of a male pseudohermaphrodite whose condition was caused by 17beta-hydroxysteroid dehydrogenase 3 (17beta-HSD3) deficiency. DESIGN: Case report. SETTING: Gynecology practice in a university teaching hospital. PATIENT(S): A 15-year-old black American male pseudohermaphrodite with 17beta-HSD3 deficiency. INTERVENTION(S): Laboratory evaluation, genetic mutation analysis, bilateral gonadectomy, and hormone replacement. MAIN OUTCOME MEASURE(S): Endocrinologic evaluation and genetic analysis. RESULT(S): A diagnosis of 17beta-HSD3 deficiency made on the basis of hormone evaluation was confirmed through genetic mutation analysis of the HSD17B3 gene. Female phenotype was attained after gonadectomy, passive vaginal dilatation, and hormone therapy. CONCLUSION(S): Deficiency of 17beta-HSD3 was diagnosed in this patient on the basis of endocrinologic evaluation and was confirmed with genetic mutation analysis. The patient was able to retain her female sexual identity after surgical and medical treatment.
OBJECTIVE: To present the clinical, biochemical, and genetic features of a male pseudohermaphrodite whose condition was caused by 17beta-hydroxysteroid dehydrogenase 3 (17beta-HSD3) deficiency. DESIGN: Case report. SETTING: Gynecology practice in a university teaching hospital. PATIENT(S): A 15-year-old black American male pseudohermaphrodite with 17beta-HSD3 deficiency. INTERVENTION(S): Laboratory evaluation, genetic mutation analysis, bilateral gonadectomy, and hormone replacement. MAIN OUTCOME MEASURE(S): Endocrinologic evaluation and genetic analysis. RESULT(S): A diagnosis of 17beta-HSD3 deficiency made on the basis of hormone evaluation was confirmed through genetic mutation analysis of the HSD17B3 gene. Female phenotype was attained after gonadectomy, passive vaginal dilatation, and hormone therapy. CONCLUSION(S): Deficiency of 17beta-HSD3 was diagnosed in this patient on the basis of endocrinologic evaluation and was confirmed with genetic mutation analysis. The patient was able to retain her female sexual identity after surgical and medical treatment.
Authors: A L Boehmer; A O Brinkmann; L A Sandkuijl; D J Halley; M F Niermeijer; S Andersson; F H de Jong; H Kayserili; M A de Vroede; B J Otten; C W Rouwé; B B Mendonça; C Rodrigues; H H Bode; P E de Ruiter; H A Delemarre-van de Waal; S L Drop Journal: J Clin Endocrinol Metab Date: 1999-12 Impact factor: 5.958
Authors: S Andersson; W M Geissler; L Wu; D L Davis; M M Grumbach; M I New; H P Schwarz; S L Blethen; B B Mendonca; W Bloise; S F Witchel; G B Cutler; J E Griffin; J D Wilson; D W Russel Journal: J Clin Endocrinol Metab Date: 1996-01 Impact factor: 5.958
Authors: B B Mendonca; M Inacio; I J Arnhold; E M Costa; W Bloise; R M Martin; F T Denes; F A Silva; S Andersson; A Lindqvist; J D Wilson Journal: Medicine (Baltimore) Date: 2000-09 Impact factor: 1.889
Authors: W M Geissler; D L Davis; L Wu; K D Bradshaw; S Patel; B B Mendonca; K O Elliston; J D Wilson; D W Russell; S Andersson Journal: Nat Genet Date: 1994-05 Impact factor: 38.330
Authors: S Bertelloni; A Balsamo; L Giordani; R Fischetto; G Russo; M Delvecchio; M Gennari; A Nicoletti; M C Maggio; D Concolino; L Cavallo; A Cicognani; G Chiumello; O Hiort; G I Baroncelli; M F Faienza Journal: J Endocrinol Invest Date: 2009-05-12 Impact factor: 4.256